← Back to Search

Positive Airway Pressure Device

APAP for Obstructive Sleep Apnea in Mental Illness

Phase 2
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
40 to 70 years old
be at risk for or have a diagnosis of obstructive sleep apnea
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial looks at whether treating sleep apnea in people with serious mental illness can improve cognition.

Who is the study for?
This trial is for adults aged 40-70 with serious mental illnesses like schizophrenia or bipolar disorder, who may also have or be at risk for obstructive sleep apnea. Participants should not have other major psychiatric conditions and must not be under conservatorship.Check my eligibility
What is being tested?
The study is testing the use of Automatic Positive Airway Pressure (APAP) machines to treat obstructive sleep apnea in individuals with serious mental illnesses, assessing how it might improve their cognitive function.See study design
What are the potential side effects?
While APAP is generally safe, side effects can include discomfort, nasal congestion, dry mouth, headaches, and sometimes difficulty sleeping when getting used to the machine.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 40 and 70 years old.
Select...
I am at risk for or have been diagnosed with obstructive sleep apnea.
Select...
I have been diagnosed with schizophrenia, schizoaffective disorder, or bipolar disorder.
Select...
I am between 40 and 70 years old.
Select...
I am at risk for or have been diagnosed with obstructive sleep apnea.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptance of PAP trial
Cognitive Functioning
Monitoring Slow Wave Sleep and Sleep Spindle Density
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Automatic Positive Airway Pressure (APAP) deviceExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,120 Previous Clinical Trials
1,521,335 Total Patients Enrolled

Media Library

Obstructive Sleep Apnea Research Study Groups: Automatic Positive Airway Pressure (APAP) device
Obstructive Sleep Apnea Clinical Trial 2023: Automatic Positive Airway Pressure (APAP) Highlights & Side Effects. Trial Name: NCT05457127 — Phase 2
Automatic Positive Airway Pressure (APAP) (Positive Airway Pressure Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05457127 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still opportunity for participants to enroll in this clinical research?

"This specific clinical trial, which had first been made available on September 1st 2022, is no longer actively recruiting subjects. Even though this particular analysis has concluded its search for participants, there are a total of 1785 alternative studies looking to recruit patients presently."

Answered by AI

Is it possible for me to take part in this medical research?

"To participate in this research, potential enrollees must be between 40-70 years of age and clinically diagnosed with manic disorder. The goal is to acquire 300 participants for the trial."

Answered by AI

Is geriatric enrollment accepted in this trial?

"This trial requires that participants are within the age range of 40 to 70 years old."

Answered by AI

Has the FDA approved Automatic Positive Airway Pressure (APAP) for public use?

"Due to the lack of clinical data on efficacy, the safety rating for Automatic Positive Airway Pressure (APAP) was assessed as a 2. This is because this particular study falls under Phase 2 trials which have some evidence supporting its safety but none suggesting effectiveness."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
UCSD
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
Recent research and studies
clinicaltrials.govStudy
Obstructive Sleep Apnea Treatment in Serious Mental Illness
Ellen Lee 2022. "Obstructive Sleep Apnea Treatment in Serious Mental Illness". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05457127.
All > Mental Illness > Bipolar Disorder
~180 spots leftby Nov 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top